Vaccine Contract Manufacturing Market

Vaccine Contract Manufacturing Market - Global
Industry Insights, Trends, Outlook, and Opportunity
Analysis, 2018–2026
Pharmaceutical and biopharmaceutical companies are focusing more on their respective core
strengths to manage the rising price pressure. Thus, the demand for contract manufacturing is
increasing. However, vaccine manufacturing is a complex venture, in which safety, effectivity,
and consistency are the most challenging part for the manufacturers. It offer many services that
include production process, construction and operation of manufacturing product, cell line
development, fermentation, process optimization, and analytical characterization, which fuels
growth of the global vaccine contract manufacturing market.
Request Sample Copy of Research Report @
Increase in research activities for new vaccines and availability of funds for the same could be
the key growth factor of vaccine contract manufacturing market
Soligenix Inc. received a fund of around US$ 2.5 million for the contract of bioterror vaccine
from National Institute of Allergy and Infectious Diseases (NIAID) in August 2017. The fund is
granted for good manufacturing practices (GMP) of RiVax bulk drug substances and finished
drug manufacturing to conduct future preclinical, clinical, and efficacy studies. Soligenix is
aiming to develop advanced Soligenix's thermostabilization technology (ThermoVax) in
combination with ricin toxin vaccine candidate – RiVax. The studies are conducting to prevent
the effects of ricin exposure.
Colorado State University’s (CSU) vaccine manufacturing facility, BioMARK, is developing a
vaccine against a mosquito borne viral pathogen, which causes Venezuelan equine encephalitis
(VEE). The U.S. Department of Defense (DoD) has funded around US$ 3 million to BioMARK for
the development of this vaccine The purpose of this vaccine is to protect U.S. soldiers from
fatal mosquito-borne pathogen. However, CSU is a subcontractor in vaccine project of Battelle
and DoD’s Medical Countermeasure Systems Joint Vaccine Acquisition Program. CSU is
determined to develop vaccine against aerosolized viruses to protect U.S. soldiers.
Emergent BioSolutions agreed to sign a contract with the Centers for Disease Control and
Prevention (CDC) for the manufacturing of BioThrax anthrax vaccine in 2016. According to the
contract, Emergent will supply over 29 million doses of BioThrax anthrax vaccine in five years
period of worth around US$ 911 million. Moreover, Biomedical Advanced Research and
Development Authority planned to order more Bio Thrax worth US$ 100 million. This would
further augment growth of the global vaccine contract manufacturing market in the near future.
Report includes chapters which deeply display the following deliverable about industry :
• Vaccine Contract Manufacturing Market Research Objective and Assumption
• Vaccine Contract Manufacturing Market Purview - Report Description, Executive Summary,
and Coherent Opportunity Map (COM)
• Vaccine Contract Manufacturing Market Dynamics, Regulations, and Trends Analysis - Market
Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system
Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Vaccine Contract Manufacturing Market, By Regions
• Vaccine Contract Manufacturing Market Competition by Manufacturers including Production,
Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Vaccine Contract Manufacturing Market Manufacturers Profiles/Analysis including Company
Basic Information, Manufacturing Base and Its Competitors.
• Vaccine Contract Manufacturing Market Manufacturing Cost Analysis including Key Raw
Materials and Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Vaccine Contract Manufacturing Market Forecast including Production, Consumption, Import
and Export Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Increasing prevalence of various viral and bacterial infections is expected to fuel growth of the
According to World Health Organization (WHO), in 2016, around three to five million cases
were recorded with severe illness and around 250,000 to 500,000 deaths were estimated due to
influenza worldwide.
In 1952, Centers for Disease Control and Prevention (CDC) collaborated with the World Health
Organization’s (WHO), under the program - Global Influenza Surveillance and Response System
(GISRS). The GISRS network consist of around 142 National Influenza Centers (NICS) worldwide,
which are conducting influenza surveillance and viral trends in 112 countries. The study helps
in research and analysis of influenza pattern and may contribute to develop candidate vaccines.
This in turn, fuels growth of the vaccine contract manufacturing market.
Request For Customization of Research Report @
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]

Pharmaceutical and biopharmaceutical companies are focusing more on their respective core strengths to manage the rising price pressure.